{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.106.11.1036",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-02-20"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.106.11.1036"
    }
  ],
  "version" : "20210220",
  "name" : "SubstanceUseDisorderTreatment",
  "title" : "Substance Use Disorder Treatment",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-02-20T01:02:00-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for encounters for substance use disorder treatment.),(Data Element Scope: This value set may use a model element related to Intervention.),(Inclusion Criteria: Includes concepts that represent an encounter for substance use disorder treatment.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "concept" : [
          {
            "code" : "G2067",
            "display" : "Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2068",
            "display" : "Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2069",
            "display" : "Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2070",
            "display" : "Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2071",
            "display" : "Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2072",
            "display" : "Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2073",
            "display" : "Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2074",
            "display" : "Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2075",
            "display" : "Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
          },
          {
            "code" : "G2076",
            "display" : "Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
          },
          {
            "code" : "G2077",
            "display" : "Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
          },
          {
            "code" : "G2080",
            "display" : "Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
          },
          {
            "code" : "G2086",
            "display" : "Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"
          },
          {
            "code" : "G2087",
            "display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"
          },
          {
            "code" : "H0020",
            "display" : "Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"
          },
          {
            "code" : "H0033",
            "display" : "Oral medication administration, direct observation"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:91592b19-784d-49e4-a354-b702f060ca8e",
    "timestamp" : "2024-06-14T16:42:38-04:00",
    "total" : 16,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2067",
        "display" : "Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2068",
        "display" : "Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2069",
        "display" : "Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2070",
        "display" : "Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2071",
        "display" : "Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2072",
        "display" : "Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2073",
        "display" : "Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2074",
        "display" : "Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2075",
        "display" : "Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2076",
        "display" : "Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2077",
        "display" : "Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2080",
        "display" : "Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2086",
        "display" : "Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G2087",
        "display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "H0020",
        "display" : "Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "H0033",
        "display" : "Oral medication administration, direct observation"
      }
    ]
  }
}
